*An updated clinical review incorporating research available up to October 2026*
## Abstract
Tension-type headache (TTH) is the most prevalent primary headache disorder worldwide. It is characterised by bilateral, pressing or tightening head pain of mild to moderate intensity. Although often considered less disabling than migraine, frequent or chronic TTH can significantly affect concentration, sleep, occupational performance and quality of life.
Current research indicates that TTH is a multifactorial neurological pain disorder involving peripheral nociceptive input, altered central pain processing, psychological influences, sleep disturbance and individual susceptibility. The diagnosis is primarily clinical and should follow the International Classification of Headache Disorders, third edition (ICHD-3). Management includes appropriate acute medication, preventive treatment when indicated, psychological interventions, lifestyle modification and selected physiotherapy approaches.
Recent systematic reviews published in 2025–2026 provide encouraging evidence for psychological interventions and evaluate the comparative effectiveness of preventive medicines. However, limitations in study quality mean that treatment decisions must remain individualised.
**Keywords:** Tension-type headache, chronic headache, central sensitisation, amitriptyline, cognitive behavioural therapy, medication-overuse headache.
## 1. Introduction
Headache is one of the most common neurological complaints encountered in clinical practice. Among primary headache disorders, tension-type headache is the most prevalent, with global prevalence estimates commonly around 26%, although estimates vary according to diagnostic criteria and the population studied. <Cite refs={["turn535577search5"]}/>
Patients typically describe a tight band around the forehead, pressure over the temples or heaviness involving both sides of the head. Unlike typical migraine, the pain is generally not aggravated by routine physical activity and is not usually associated with vomiting.
Despite these relatively mild features, frequent headache can substantially affect daily life. A patient experiencing headache on most working days may have difficulty concentrating, sleeping properly or maintaining productivity, even if the pain is never severe.
TTH is also frequently misunderstood. It is not simply a headache caused by stress or tight muscles. Modern research recognises an interaction between peripheral pain mechanisms, central nervous system processing and psychosocial factors.
A structured clinical approach is therefore essential, particularly when headache becomes frequent, medication use increases or symptoms change.
## 2. Classification and diagnostic criteria
The International Classification of Headache Disorders, third edition (ICHD-3), divides TTH into the following categories.
### 2.1 Infrequent episodic TTH
Headache occurs on fewer than one day per month on average, or fewer than 12 days per year. Treatment usually involves education, reassurance and occasional acute medication when necessary.
### 2.2 Frequent episodic TTH
Headache occurs on 1–14 days per month on average for more than three months. Patients may begin experiencing interference with work or studies and may increasingly rely on painkillers.
### 2.3 Chronic TTH
Headache occurs on at least 15 days per month for more than three months. Pain may last hours or days and can become continuous.
Chronic TTH may coexist with sleep disturbance, anxiety, depression and medication-overuse headache. Preventive treatment and regular follow-up are often required.
### 2.4 Probable TTH
This category applies when a headache meets all but one of the required criteria for a recognised TTH subtype and is not better explained by another headache disorder.
### Typical clinical features
The characteristic features include:
- Bilateral pain involving the forehead, temples, sides or back of the head.
- Pressing, tightening or aching rather than distinctly pulsating pain.
- Mild to moderate intensity.
- No aggravation by ordinary physical activity.
- No vomiting or moderate to severe nausea.
- No more than one of photophobia, phonophobia or mild nausea under the relevant ICHD-3 criteria.
An episodic attack typically lasts from 30 minutes to seven days.
These features should be assessed together. A band-like headache alone is not sufficient to establish the diagnosis.
The full diagnostic criteria are available from the [International Headache Society's ICHD-3 classification](https://ichd-3.org/2-tension-type-headache-tth/).
## 3. Pathophysiology: Understanding the mechanisms
The precise mechanisms of TTH remain incompletely understood. Current evidence supports a multifactorial model involving peripheral and central pain processing.
### 3.1 Peripheral pain mechanisms
Tenderness of the muscles and connective tissues around the head and neck is common in some patients. Sustained muscular loading, jaw clenching, prolonged static posture and local musculoskeletal discomfort may contribute to pain.
However, muscular tension is not present in every patient, and its presence does not prove that it is the primary cause of headache.
### 3.2 Central sensitisation
Central sensitisation refers to increased responsiveness within central pain-processing pathways. In some patients, repeated nociceptive input may contribute to heightened pain sensitivity.
This mechanism is particularly relevant to chronic TTH, in which pain may persist even without an obvious muscular abnormality. It helps explain why chronic headache should not be treated as a purely muscular condition.
### 3.3 Impaired pain inhibition
The brain and brainstem contain pathways that can suppress or amplify pain signals. Research suggests that pain-inhibitory mechanisms may function less effectively in some patients with chronic TTH.
Consequently, ordinary sensory input may be experienced as more uncomfortable or painful.
### 3.4 Psychological and lifestyle influences
Stress, anxiety, depression, poor sleep and sustained physical inactivity may influence headache frequency and pain perception. Their relationship with headache is often bidirectional: stress may aggravate headache, while persistent pain may increase emotional distress.
Neuroimaging studies have also identified differences in brain regions involved in pain processing and emotional regulation. These findings remain research observations and are not diagnostic biomarkers.
The 2025 review by Pan and colleagues emphasises that TTH involves interacting neurological, musculoskeletal and psychosocial mechanisms rather than a single cause. <Cite refs={["turn535577search5"]}/>
## 4. Clinical assessment and differential diagnosis
Diagnosis is primarily based on a detailed history and physical examination.
The clinician should establish the onset, location, quality, duration, severity and monthly frequency of headache. Associated symptoms, medication use, sleep quality, stress and functional impairment should also be assessed.
A headache diary is particularly useful for recording headache days, medication-use days and response to treatment.
### Important differential diagnoses
**Migraine:** Migraine may also cause bilateral or pressing pain. Nausea, vomiting, combined light and sound sensitivity, or aggravation by routine activity may favour migraine, although overlap occurs.
**Cervicogenic headache:** This is attributed to a cervical spine or related musculoskeletal disorder. Restricted neck movement and reproducible headache with specific neck movements may support the diagnosis. Neck pain alone is insufficient.
**Medication-overuse headache:** This should be considered when headache becomes persistent in association with frequent use of acute headache medication. Under ICHD-3, relevant overuse thresholds generally involve regular use for more than three months, with thresholds depending on the medication class.
**Secondary headache:** Intracranial, vascular, infectious and other systemic conditions may cause headache resembling TTH. Warning features must be assessed before a primary headache diagnosis is accepted.
### Red flags
Urgent assessment is required for a sudden, explosive headache; new neurological deficits; fever with neck stiffness; altered consciousness; significant head trauma; or a new headache associated with pregnancy, postpartum complications, cancer or immunosuppression.
Progressively worsening headache, repeated vomiting or a substantial change in an established pattern also warrants further assessment.
Routine brain imaging is generally unnecessary for a typical, stable presentation with a normal neurological examination and no warning signs. Investigations should be guided by the suspected underlying cause.
## 5. Evidence-based treatment
Treatment aims to reduce pain, decrease headache frequency, prevent medication overuse and improve quality of life.
The approach should depend on headache frequency, disability, medical history and patient preferences.
### 5.1 Acute treatment
For occasional episodic TTH, appropriate acute options include:
- Paracetamol.
- Ibuprofen.
- Naproxen.
Selection depends on contraindications, other medicines and previous treatment response.
NSAIDs can cause gastrointestinal bleeding, kidney injury and cardiovascular complications in susceptible patients. Paracetamol requires caution in liver disease and when other products containing the same ingredient are used.
Patients should follow appropriate prescribing or product guidance and avoid combining medicines without professional advice.
Triptans and opioids are generally not recommended for correctly diagnosed TTH. If symptoms suggest migraine, the diagnosis should be reconsidered rather than repeatedly escalating TTH treatment.
### 5.2 Preventive treatment
Preventive therapy should be considered when headache is frequent, chronic, disabling or associated with repeated need for acute medication.
**Amitriptyline** has the strongest established role among preventive medicines for chronic TTH. It may influence pain-modulating pathways and can be useful in selected patients who also experience sleep disturbance.
Treatment is generally started at a low dose, such as 10 mg at bedtime, and adjusted gradually by the prescribing clinician according to response and tolerability.
Potential adverse effects include drowsiness, dry mouth, constipation, weight gain and dizziness. Cardiac conditions, drug interactions and other contraindications must be considered.
Other medicines, including venlafaxine and mirtazapine, have been investigated, but the evidence is less established than for amitriptyline. Treatment should be individualised rather than based solely on a medicine's drug class.
### 5.3 What does the latest pharmacological research show?
A 2026 systematic review and network meta-analysis included 35 randomised controlled trials of preventive pharmacological treatment for TTH. It reported potential benefits from some regimens, including amitriptyline, but highlighted low to very low certainty for important comparisons because of study limitations and heterogeneity. <Cite refs={["turn535577search3"]}/>
Botulinum toxin type A has also been investigated for chronic TTH. Although some analyses suggest potential benefits, the evidence is not sufficiently consistent to establish it as routine first-line treatment.
These findings underline the importance of distinguishing promising results from established clinical recommendations.
## 6. Psychological interventions: Recent evidence
Psychological interventions are increasingly recognised as useful components of headache management. They aim to improve coping, reduce stress-related arousal and address behavioural factors that may perpetuate pain.
### Cognitive behavioural therapy
Cognitive behavioural therapy (CBT) helps patients identify unhelpful thoughts and behaviours associated with headache and develop more effective coping strategies.
It may be useful for patients experiencing persistent pain-related anxiety, avoidance of normal activities or difficulty managing stress.
### Relaxation and mindfulness
Progressive muscle relaxation, controlled breathing and mindfulness-based techniques may help selected patients manage distress and improve awareness of factors associated with their symptoms.
These interventions are supportive treatments, not guaranteed cures, and should not replace appropriate medical assessment.
### Findings from the 2025–2026 systematic review
A systematic review by Yuan and colleagues, published online in November 2025 and included in the journal's 2026 volume, evaluated psychological interventions for TTH. It included 19 studies involving 1,069 participants.
The pooled analysis of five studies, involving 383 participants, estimated approximately 4.53 fewer headache days per month in intervention groups compared with control groups. The authors also reported improvements in treatment response, while noting variation between studies and the need for better-quality trials. <Cite refs={["turn535577search2"]}/>
This is encouraging evidence, but the pooled estimate should not be interpreted as a guaranteed reduction for every patient.
The practical implication is that psychological interventions deserve consideration, particularly for people with frequent headache, stress-related difficulties or persistent disability.
## 7. Physiotherapy and lifestyle modification
Physiotherapy may help patients with relevant cervical or shoulder impairments, muscular tenderness or reduced mobility. Treatment may include individualised exercises, mobility work, postural endurance training and education.
Manual therapy and trigger-point techniques have shown potential benefits in some studies, but treatment protocols and study quality vary. These approaches should be considered adjuncts rather than stand-alone cures. <Cite refs={["turn535577search4"]}/>
Lifestyle management should focus on realistic, sustainable changes.
- **Sleep:** Maintain a reasonably consistent sleep schedule and seek assessment for persistent insomnia or suspected sleep disorders.
- **Hydration and meals:** Maintain adequate fluid intake and regular meals, particularly when missed meals or dehydration repeatedly coincide with symptoms.
- **Caffeine:** Review high or irregular caffeine intake and avoid abrupt withdrawal when gradual reduction is more appropriate.
- **Ergonomics:** Adjust the workstation and take movement breaks during prolonged sitting.
- **Exercise:** Incorporate regular physical activity according to individual ability.
- **Stress management:** Consider relaxation practice, counselling or CBT when appropriate.
No single lifestyle measure prevents every headache. The purpose is to identify relevant contributing factors without placing unrealistic responsibility on the patient.
## 8. Practical management in Pakistan
In Pakistan, patients may initially self-medicate or consult several healthcare providers before receiving a clear diagnosis. Repeated analgesic use, affordability and limited access to specialist services can complicate management.
Primary-care clinicians can help by recognising typical TTH, explaining safe medication use, identifying warning signs and arranging follow-up.
For frequent or chronic headache, the clinician should review the diagnosis, medication-use pattern, disability and potential need for preventive treatment. Patients who do not respond to appropriate management or have an uncertain diagnosis may require neurologist assessment.
Treatment plans should take account of work schedules, family responsibilities, financial circumstances and access to psychological or rehabilitation services.
There is also a need for more locally representative research in Pakistan on headache prevalence, medication use, diagnostic patterns and treatment outcomes.
## 9. Monitoring and future research
Treatment effectiveness should be assessed using more than pain intensity alone. Important outcomes include monthly headache days, functional impairment, acute medication use, sleep quality, adverse effects and overall quality of life.
A headache diary can establish a baseline and help determine whether preventive treatment is working.
Future research should improve diagnostic classification, develop better treatment trials and investigate whether clinical or biological markers can predict individual treatment response. At present, there is no validated biomarker that can reliably diagnose TTH or select the best treatment.
Digital headache diaries and telemedicine may improve monitoring and access to specialist care, although they cannot replace urgent assessment when warning signs are present.
Research into integrated care models combining medical treatment, psychological interventions and physiotherapy may also help determine which combinations provide the greatest long-term benefit.
## 10. Conclusion
Tension-type headache is the most prevalent primary headache disorder, but its impact should not be underestimated. Frequent and chronic disease can interfere substantially with work, education, sleep and quality of life.
Contemporary research supports a multifactorial model involving peripheral pain input, central pain processing, psychological influences and lifestyle-related factors. Diagnosis remains clinical and requires careful differentiation from migraine, medication-overuse headache and secondary headache disorders.
Occasional episodic TTH can often be managed with education and appropriate acute treatment. Frequent or chronic headache may require preventive medication, particularly amitriptyline when suitable, alongside behavioural interventions and selected physiotherapy approaches.
Recent research supports the potential benefits of psychological interventions, while pharmacological comparisons highlight continuing uncertainty about the optimal treatment for every patient.
**The key clinical message is that TTH should neither be dismissed as ordinary stress nor managed with painkillers alone when it becomes frequent or disabling.** Accurate diagnosis, safe prescribing, individualised prevention and regular follow-up remain the foundations of effective care.
## References and further reading
1. Pan LLH, Ling YH, Wang SJ, et al. *Hallmarks of primary headache: part 2—Tension-type headache.* The Journal of Headache and Pain. 2025;26:164. [Full review](https://doi.org/10.1186/s10194-025-02098-w).
2. Yuan L, Pantila K, Niu XY, et al. *Efficacy of psychological treatment for tension-type headache: a systematic review and meta-analysis.* The Journal of Headache and Pain. Published online 2025; included in volume 27 (2026). [Full article](https://doi.org/10.1186/s10194-025-02237-3).
3. *Comparative effects of pharmacological interventions in the prophylactic treatment of tension-type headache: systematic review and network meta-analysis.* 2026. [Full article](https://doi.org/10.1080/07853890.2026.2616972).
4. Bravo-Vazquez A, Anarte-Lazo E, Perez-Alvarez A, et al. *Tension-Type Headache: Toward an Integrative Multidimensional Framework for Clinical Stratification and Personalized Management.* Journal of Clinical Medicine. 2026;15(8):2984. [Full article](https://doi.org/10.3390/jcm15082984).
5. Steelquist J, Pham A, Vu K, Eapen BC. *Assessment and Management of Tension-Type Headaches.* Physical Medicine and Rehabilitation Clinics of North America. 2025;36(4):715–725. [PubMed](https://pubmed.ncbi.nlm.nih.gov/41167852/).
6. International Headache Society. *International Classification of Headache Disorders, third edition (ICHD-3): Tension-type headache.* [Diagnostic criteria](https://ichd-3.org/2-tension-type-headache-tth/).
7. National Institute for Health and Care Excellence. *Headaches in over 12s: diagnosis and management.* Clinical guideline CG150, updated 2025. [Guideline](https://www.nice.org.uk/guidance/cg150).
8. British Association for the Study of Headache. *Guidelines for All Healthcare Professionals in the Diagnosis and Management of Headache.* 2026. [Clinical guidance](https://bash.org.uk/2-3-3-tension-type-headache-management/).
*Editorial note: This is an evidence-informed clinical review, not a formally registered systematic review. Treatment and medication dosing should be individualised by a qualified healthcare professional.*
